Best Noom Alternatives
Noom scores 59.8/100 in our independent evaluation, but it isn't the right fit for everyone. The most common reasons people look elsewhere: $56m class action settlement over autorenewal/cancellation practices; bbb 'd' rating with 1,200+ complaints; and coaching quality criticized as automated/templated rather than personalized. Here are the 8 brands that compete with it most directly, ranked by category overlap and overall score.
Read our full Noom review for the complete score breakdown.
Publicly traded telehealth betting big on weight loss, with aggressive GLP-1 pricing and fast-growing subscriber base.
- ▸Higher overall score (68/100 vs 59.8/100)
- ▸Better value score (75 vs 60)
- ▸Lower starting price ($14/mo vs $17/mo)
Men's telehealth platform best known for its compounded sublingual ED treatment combining sildenafil, tadalafil, and apomorphine in a single fast-acting dose.
- ▸Higher overall score (65.5/100 vs 59.8/100)
- ▸Also treats Sexual Health, Men's Health, Hair Loss
DTC telehealth platform specializing in compounded GLP-1 weight-loss medications with flat-rate dose-independent pricing and the world's first compounded GLP-1 gummy.
- ▸Higher overall score (63.8/100 vs 59.8/100)
- ▸Better value score (70 vs 60)
- ▸Also treats Men's Health, Sexual Health, Hair Loss
TRT-focused telehealth clinic specializing in daily microdosing testosterone protocols with bundled monitoring, serving 100,000+ men since 2018.
- ▸Higher overall score (62/100 vs 59.8/100)
- ▸Also treats Men's Health, Sexual Health
GLP-1 telehealth platform with peer-reviewed clinical outcomes data, offering compounded semaglutide and tirzepatide alongside women's hormone therapy across 49 states.
- ▸Better value score (70 vs 60)
- ▸Also treats Women's Health
The largest publicly traded D2C telehealth platform, offering treatments across hair loss, ED, mental health, skincare, and weight loss.
- ▸Higher overall score (77.5/100 vs 59.8/100)
- ▸Stronger trust & safety score (75 vs 65)
- ▸Better value score (70 vs 60)
Vertically integrated private telehealth with in-house pharmacy, diagnostics, and an Eli Lilly partnership for branded GLP-1s.
- ▸Higher overall score (77/100 vs 59.8/100)
- ▸Stronger trust & safety score (85 vs 65)
- ▸Lower starting price ($13/mo vs $17/mo)
Women-focused telehealth delivering personalized bioidentical hormone replacement therapy for menopause, with in-house compounding pharmacies across 33 states.
- ▸Higher overall score (74.5/100 vs 59.8/100)
- ▸Better value score (75 vs 60)
- ▸Lower starting price ($9/mo vs $17/mo)
Not sure which fits? Answer a few questions and we'll match you.
Take the Match Quiz